| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/18/2009 | US20090156513 freeze-dried fruit pulp powder; antioxidants comprises a high concentration of anthocyanin; treating disease or injury and damage induced by pathological free radicals; has a cyclooxygenase inhibition value greater than Aspirin; anticarcinogenic, antiinflammatory, antiarthritic agents; aging resistance |
| 06/18/2009 | US20090156507 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 06/18/2009 | US20090156493 Urocortin-iii and uses thereof |
| 06/18/2009 | US20090156492 Methods of Using IL-1 Antagonists to Treat Autoinflammatory Disease |
| 06/18/2009 | US20090156484 Use of Transferrins for Treating Destructive Inflammation of Mucous Membrane |
| 06/18/2009 | US20090156477 Compositions and Methods for Regulating Inflammatory Responses |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155845 Molecules designated LDCAM |
| 06/18/2009 | US20090155398 Jucara and acai fruit-based dietary supplements |
| 06/18/2009 | US20090155374 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155273 Remedies for inflammatory bowel diseases |
| 06/18/2009 | US20090155266 Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155186 Compositions and methods for treating inflammatory conditions |
| 06/18/2009 | US20090155164 Human c-fms antigen binding proteins |
| 06/18/2009 | DE102007059752A1 Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone Functionalized solid polymer nanoparticles comprising epothilones |
| 06/18/2009 | CA2714401A1 Nutraceutical composition and methods of use |
| 06/18/2009 | CA2714399A1 Nutraceutical composition and methods of use |
| 06/18/2009 | CA2709314A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2708352A1 Anti-inflammatory compositions and combinations |
| 06/18/2009 | CA2708233A1 Tape preparation comprising etodolac in ionic liquid form |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070927A1 Fused heterocyclic derivative |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070920A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 06/17/2009 | EP2070919A1 Spiroquinone compound and pharmaceutical composition |
| 06/17/2009 | EP2070908A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 06/17/2009 | EP2070525A1 Compositions comprising Magnolol and/or Honokiol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/17/2009 | EP2070524A1 Compositions comprising Magnolol and/or Honokiol and glucosamine and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/17/2009 | EP2070523A1 Composition comprising Magnolol and Honokiol in synergistic amount |
| 06/17/2009 | EP2069359A1 Aza-benzothiophenyl compounds and methods of use |
| 06/17/2009 | EP2069354A1 Aza-benzofuranyl compounds and methods of use |
| 06/17/2009 | EP2069341A1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors |
| 06/17/2009 | EP2069309A1 Ion channel modulators&uses thereof |
| 06/17/2009 | EP2069296A2 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 06/17/2009 | EP2068908A1 A milk protein composition and use thereof |
| 06/17/2009 | EP2068895A1 Selective chemokine modulation |
| 06/17/2009 | EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 06/17/2009 | EP2068870A2 Thiophene compounds |
| 06/17/2009 | EP2068833A2 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 06/17/2009 | EP1866306B1 Imidazopyridine derivatives useful as inos inhibitors |
| 06/17/2009 | EP1709056B1 Phosphoramidate derivatives |
| 06/17/2009 | EP1603921B1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases |
| 06/17/2009 | EP1565431B1 Cannabinoid receptor ligands |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1435957B1 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | EP1322592B2 Substituted 1-aminobutan-3-ol derivatives |
| 06/17/2009 | CN101460223A Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/17/2009 | CN100500210C Use of il-18 inhibitors in hypersensitivity disorders |
| 06/17/2009 | CN100500200C Fuyankang pills against gynecologic inflammation and their preparation |
| 06/17/2009 | CN100500164C Process for preparing bee glue water solution and use |
| 06/16/2009 | US7547543 Retinoid-Related Orphan Receptor (ROR) receptor response element ; drug screening |
| 06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 06/16/2009 | CA2487365C Piperidine derivatives as potassium channel blockers |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2330500C Pharmaceutical compositions capable of being gelled |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2278201C Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073683A2 Methods of treating copd |
| 06/11/2009 | WO2009073300A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/11/2009 | WO2009073203A1 Trp-m8 receptor ligands and their use in treatments |
| 06/11/2009 | WO2009072604A1 Anti-nr10 antibody and use thereof |
| 06/11/2009 | WO2009071905A2 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 06/11/2009 | WO2009071901A1 A substituted thieno-pyridinone kinase inhibitor |
| 06/11/2009 | WO2009071895A1 Fused thiazole and thiophene derivatives as kinase inhibitors |
| 06/11/2009 | WO2009071890A1 Tricyclic kinase inhibitors |
| 06/11/2009 | WO2009071753A1 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 06/11/2009 | WO2009071658A1 Piperazines as anti-obesity agents |
| 06/11/2009 | WO2009071033A1 Method for improving the stability and bioavailability of lipid extract of cucurbita pepo l. seeds and resulting composition |
| 06/11/2009 | WO2009070829A1 Non-aqueous oil-based fentanyl compositions for transmucosal administration |
| 06/11/2009 | WO2009055629A3 Cyclohexeneamide derivatives and their use as trpv1 antagonist |
| 06/11/2009 | WO2009044006A3 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid the pharmaceutically-acceptable esters and salts and solvates thereof for use as medicament |
| 06/11/2009 | WO2008098788A3 Receptor and antigen targeted prodrug |
| 06/11/2009 | WO2008063300A8 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 06/11/2009 | US20090149543 Solid pharmaceutical compositions comprising lumiracoxib |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149533 Novel fenofibrate formulations and related methods of treatment |
| 06/11/2009 | US20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |
| 06/11/2009 | US20090149501 administering [7-(benzyloxy)-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone to mammals as analgesics, antiinflammatory agents and as neuroprotectants |
| 06/11/2009 | US20090149500 solid forms of lenalidomide, treating cancer, inflammatory disease, myelodysplastic syndrome, undesired angiogenesis |
| 06/11/2009 | US20090149494 THERAPEUTIC USE OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES |
| 06/11/2009 | US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149437 Thieno-pyridine derivatives as mek inhibitors |
| 06/11/2009 | US20090149433 Compositions for the treatment of inflammation of the gastrointestinal tract |
| 06/11/2009 | US20090149430 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament |